AstraZeneca (AZN), Rigel (RIGL) in Exclusive License Agreement for JAK Inhibitor R256
Go back to AstraZeneca (AZN), Rigel (RIGL) in Exclusive License Agreement for JAK Inhibitor R256| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 16,889 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 46.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.96 | 52 Week High | $4.38 | |||
| Open | $46.96 | 52 Week Low | $1.88 | |||
| Day High | $46.96 | P/E | N/A | |||
| Day Low | $46.96 | EPS | $-1.12 | |||
| Volume | 77 | |||||

